Sastasundar Ventures Limited has informed the Exchange about Investor Presentation
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures filed its June 2025 Investor Presentation with the exchanges. The deck shows a sharp decline in performance: FY25 revenue from operations fell 19.7% YoY to Rs. 1,088.5 Cr from Rs. 1,355.2 Cr, and full-year gross profit dropped 41.9% to Rs. 71.1 Cr with GP margin compressing to 6.5% (from 9.0%). FY25 EBITDA loss widened to Rs. 78.5 Cr (margin -7.2%) and the company reported a net loss of Rs. 133.5 Cr, largely due to a Rs. 190.6 Cr exceptional item. Q4 FY25 revenue was Rs. 281.9 Cr (-6.8% YoY) with an EBITDA loss of Rs. 29.1 Cr. On the positive side, the company highlighted that working capital days improved 34% YoY to 23 days, and liquid assets grew to Rs. 656 Cr while borrowings remained at zero.
Negative near-term sentiment likely as revenue and margins have deteriorated sharply, though the company remains debt-free with strong liquid assets of Rs. 656 Cr and improving working capital efficiency, which may limit downside. Shareholders should watch for clarity on the nature of the Rs. 190.6 Cr exceptional charge and the path to revenue recovery.